Suppr超能文献

慢性胃蛋白酶暴露促进下咽鳞癌细胞系的锚定非依赖性生长和迁移。

Chronic pepsin exposure promotes anchorage-independent growth and migration of a hypopharyngeal squamous cell line.

机构信息

Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

出版信息

Otolaryngol Head Neck Surg. 2014 Apr;150(4):618-24. doi: 10.1177/0194599813517862. Epub 2013 Dec 27.

Abstract

OUTCOME OBJECTIVES

(1) Investigate the role of reflux, specifically pepsin, in laryngopharyngeal carcinogenesis. (2) Evaluate effects of chronic pepsin exposure on cell migration, apoptosis, and colony-forming ability in hypopharyngeal cells.

STUDY DESIGN

Translation research.

SETTING

Academic research laboratory.

METHODS

Human hypopharyngeal squamous carcinoma FaDu cells were chronically exposed to nonacidic pepsin (exposed for 24 hours, 4 times over 2 weeks at the following concentrations: 0.01 mg/mL, 0.1 mg/mL, or 1 mg/mL). Precise wounds were created in confluent cell plates, and rates of cell migration into wounds were quantified. Separately, cell viability of chronic pepsin-exposed FaDu cells acutely treated with paclitaxel was measured. Finally, a clonogenic assay was performed on these cells to measure effects of chronic pepsin exposure on colony-forming ability.

RESULTS

An increased rate of relative wound density was observed in chronic pepsin-treated (0.01 mg/mL, 0.1 mg/mL) cells compared with control (P < .001), suggesting greater rates of cell migration. Pepsin-treated (0.1 mg/mL) cells demonstrated on average greater cell viability compared with control after exposure to paclitaxel, suggesting possible apoptotic resistance; however, this was not statistically significant. Chronic pepsin exposure (0.1 mg/mL, 1 mg/mL) was associated with a dose-dependent increase in colony-forming ability relative to control (P < .001).

CONCLUSION

Hypopharyngeal squamous cell line chronically exposed to pepsin demonstrated increased cell migration and colony-forming ability relative to control cells. These experiments indicate that chronic pepsin exposure acts as a promoter of tumorigenesis and metastasis of airway epithelium, suggesting a role for pepsin in laryngopharyngeal carcinogenesis attributed to gastric reflux.

摘要

目的

(1)研究反流,特别是胃蛋白酶,在咽喉癌发生中的作用。(2)评估慢性胃蛋白酶暴露对下咽细胞迁移、凋亡和集落形成能力的影响。

研究设计

翻译研究。

地点

学术研究实验室。

方法

用人下咽鳞癌细胞系 FaDu 细胞进行慢性非酸性胃蛋白酶暴露(暴露 24 小时,2 周内分 4 次,浓度分别为 0.01mg/ml、0.1mg/ml 或 1mg/ml)。在汇合的细胞板上精确地制造伤口,并量化细胞迁移到伤口的速度。分别测量慢性胃蛋白酶暴露的 FaDu 细胞在急性紫杉醇处理后的细胞活力。最后,对这些细胞进行集落形成试验,以测量慢性胃蛋白酶暴露对集落形成能力的影响。

结果

与对照组相比,慢性胃蛋白酶处理(0.01mg/ml、0.1mg/ml)细胞的相对伤口密度增加率更高(P<0.001),提示细胞迁移速度更快。与对照组相比,暴露于紫杉醇后,胃蛋白酶处理(0.1mg/ml)细胞的平均细胞活力更高,提示可能存在凋亡抵抗;但这没有统计学意义。与对照组相比,慢性胃蛋白酶暴露(0.1mg/ml、1mg/ml)与集落形成能力呈剂量依赖性增加(P<0.001)。

结论

与对照组相比,慢性暴露于胃蛋白酶的下咽鳞癌细胞系显示出更高的细胞迁移和集落形成能力。这些实验表明,慢性胃蛋白酶暴露作为气道上皮肿瘤发生和转移的促进剂,提示胃蛋白酶在胃食管反流引起的咽喉癌发生中起作用。

相似文献

1
Chronic pepsin exposure promotes anchorage-independent growth and migration of a hypopharyngeal squamous cell line.
Otolaryngol Head Neck Surg. 2014 Apr;150(4):618-24. doi: 10.1177/0194599813517862. Epub 2013 Dec 27.
2
Pepsin promotes proliferation of laryngeal and pharyngeal epithelial cells.
Laryngoscope. 2012 Jun;122(6):1317-25. doi: 10.1002/lary.23307. Epub 2012 May 8.
3
Pepsin in nonacidic refluxate can damage hypopharyngeal epithelial cells.
Ann Otol Rhinol Laryngol. 2009 Sep;118(9):677-85. doi: 10.1177/000348940911800913.
4
6
Pepsin as a causal agent of inflammation during nonacidic reflux.
Otolaryngol Head Neck Surg. 2009 Nov;141(5):559-63. doi: 10.1016/j.otohns.2009.08.022.
8
Pepsin promotes laryngopharyngeal neoplasia by modulating signaling pathways to induce cell proliferation.
PLoS One. 2020 Jan 15;15(1):e0227408. doi: 10.1371/journal.pone.0227408. eCollection 2020.
9
Receptor-mediated uptake of pepsin by laryngeal epithelial cells.
Ann Otol Rhinol Laryngol. 2007 Dec;116(12):934-8. doi: 10.1177/000348940711601211.
10
Bile reflux and hypopharyngeal cancer (Review).
Oncol Rep. 2021 Nov;46(5). doi: 10.3892/or.2021.8195. Epub 2021 Sep 24.

引用本文的文献

1
Inhaled fosamprenavir for laryngopharyngeal reflux: Toxicology and fluid dynamics modeling.
Laryngoscope Investig Otolaryngol. 2024 Jan 24;9(1):e1219. doi: 10.1002/lio2.1219. eCollection 2024 Feb.
2
Amprenavir inhibits pepsin-mediated laryngeal epithelial disruption and E-cadherin cleavage in vitro.
Laryngoscope Investig Otolaryngol. 2023 Jun 22;8(4):953-962. doi: 10.1002/lio2.1102. eCollection 2023 Aug.
5
Pepsin enhances glycolysis to promote malignant transformation of vocal fold leukoplakia epithelial cells with dysplasia.
Eur Arch Otorhinolaryngol. 2023 Apr;280(4):1841-1854. doi: 10.1007/s00405-022-07729-5. Epub 2022 Nov 16.
6
The role of Glut-1 and H/K-ATPase expression in hyperplasia of mice laryngeal epithelium induced by pepsin.
Eur Arch Otorhinolaryngol. 2022 Jun;279(6):2981-2987. doi: 10.1007/s00405-021-07221-6. Epub 2022 Jan 27.
7
How I Approach Laryngopharyngoesophageal Reflux (LPR).
Curr Gastroenterol Rep. 2021 Nov 19;23(12):27. doi: 10.1007/s11894-021-00823-4.
9
Presence of pepsin in laryngeal tissue and saliva in benign and malignant neoplasms.
Biosci Rep. 2020 Nov 27;40(11). doi: 10.1042/BSR20200216.
10
Pepsin promotes laryngopharyngeal neoplasia by modulating signaling pathways to induce cell proliferation.
PLoS One. 2020 Jan 15;15(1):e0227408. doi: 10.1371/journal.pone.0227408. eCollection 2020.

本文引用的文献

1
Relationship between reflux and laryngeal cancer.
Head Neck. 2013 Dec;35(12):1814-8. doi: 10.1002/hed.23208. Epub 2013 Jun 22.
2
Gastric reflux is an independent risk factor for laryngopharyngeal carcinoma.
Cancer Epidemiol Biomarkers Prev. 2013 Jun;22(6):1061-8. doi: 10.1158/1055-9965.EPI-13-0183. Epub 2013 May 23.
3
Pepsin promotes proliferation of laryngeal and pharyngeal epithelial cells.
Laryngoscope. 2012 Jun;122(6):1317-25. doi: 10.1002/lary.23307. Epub 2012 May 8.
4
The cadherin-catenin complex in laryngeal squamous cell carcinoma.
Eur Arch Otorhinolaryngol. 2012 Apr;269(4):1183-8. doi: 10.1007/s00405-011-1892-4. Epub 2011 Dec 25.
5
The role of laryngopharyngeal reflux as a risk factor in laryngeal cancer: a preliminary report.
Clin Exp Otorhinolaryngol. 2011 Jun;4(2):101-4. doi: 10.3342/ceo.2011.4.2.101. Epub 2011 May 31.
6
Rationale for targeting pepsin in the treatment of reflux disease.
Ann Otol Rhinol Laryngol. 2010 Aug;119(8):547-58. doi: 10.1177/000348941011900808.
7
Pepsin as a causal agent of inflammation during nonacidic reflux.
Otolaryngol Head Neck Surg. 2009 Nov;141(5):559-63. doi: 10.1016/j.otohns.2009.08.022.
8
Pepsin in nonacidic refluxate can damage hypopharyngeal epithelial cells.
Ann Otol Rhinol Laryngol. 2009 Sep;118(9):677-85. doi: 10.1177/000348940911800913.
9
Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.
Ann Otol Rhinol Laryngol. 2008 Sep;117(9):688-95. doi: 10.1177/000348940811700911.
10
Characteristics of symptomatic reflux episodes on Acid suppressive therapy.
Am J Gastroenterol. 2008 May;103(5):1090-6. doi: 10.1111/j.1572-0241.2008.01791.x. Epub 2008 Apr 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验